VolitionRx Ltd
VNRX
31 hedge funds and large institutions have $17.5M invested in VolitionRx Ltd in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 3 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
84% more capital invested
Capital invested by funds: $9.51M → $17.5M (+$7.96M)
24% more funds holding
Funds holding: 25 → 31 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.38% → 0.38% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$358K |
| 2 |
Morgan Stanley
New York
|
+$209K |
| 3 |
Renaissance Technologies
New York
|
+$200K |
| 4 |
JP Morgan Chase
New York
|
+$165K |
| 5 |
VF
Virtu Financial
New York
|
+$80.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
-$501K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$116K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$107K |
| 4 |
LCM
Leisure Capital Management
Costa Mesa,
California
|
-$42K |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
-$31K |
VNRX Hedge Fund Activity: Q3 2019 in Review
31 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2019, worth a combined $17.5M — up 84% from $9.51M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VNRX positions and 3 closed out — a net gain of 6 holders — while 10 added to existing stakes and 3 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $358K. The largest seller was Lagoda Investment Management, cutting an estimated $501K.
- 31 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2019, up from 25 in Q2 2019.
- Funds reported $17.5M of VolitionRx Ltd stock for Q3 2019, up 84% quarter-over-quarter.
- 9 funds opened new VolitionRx Ltd positions in Q3 2019 and 3 closed out, a net change of +6 holders.
- The largest VolitionRx Ltd buyer in Q3 2019 was Geode Capital Management, an estimated $358K added.
- The largest VolitionRx Ltd seller in Q3 2019 was Lagoda Investment Management, an estimated $501K sold.
Based on aggregated 13F filings for Q3 2019.